RELAPSED OR REFRACTORY PLASMA CELL NEOPLASMS
Clinical trials for RELAPSED OR REFRACTORY PLASMA CELL NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new RELAPSED OR REFRACTORY PLASMA CELL NEOPLASMS trials appear
Sign up with your email to follow new studies for RELAPSED OR REFRACTORY PLASMA CELL NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Double-barreled CAR-T takes aim at hard-to-treat blood cancers
Disease control Not yet recruitingThis early-phase study tests a new type of immunotherapy called CAR19-BCMA CAR-T for people with certain blood cancers (plasma cell neoplasms, lymphomas, or leukemias) that have relapsed or stopped responding to at least three prior treatments. The therapy uses a patient's own im…
Matched conditions: RELAPSED OR REFRACTORY PLASMA CELL NEOPLASMS
Phase: EARLY_PHASE1 • Sponsor: Affiliated Hospital to Academy of Military Medical Sciences • Aim: Disease control
Last updated May 26, 2026 12:12 UTC
-
Double-Target cell therapy takes on tough blood cancers
Disease control Not yet recruitingThis early-phase study tests a new treatment called CAR70-BCMA CAR-T for people with plasma cell cancers (like multiple myeloma) that have returned or stopped responding to standard therapy. The treatment uses a patient's own immune cells, modified to attack two cancer targets at…
Matched conditions: RELAPSED OR REFRACTORY PLASMA CELL NEOPLASMS
Phase: EARLY_PHASE1 • Sponsor: The General Hospital of Western Theater Command • Aim: Disease control
Last updated May 26, 2026 12:08 UTC
-
Double-barreled CAR-T takes aim at hard-to-treat blood cancer
Disease control Not yet recruitingThis early-phase study tests a new cell therapy that targets two markers (BCMA and CD70) on high-risk plasma cell cancers, including multiple myeloma. About 20 participants will receive the treatment to see if it is safe and how well it works. The goal is to control the disease, …
Matched conditions: RELAPSED OR REFRACTORY PLASMA CELL NEOPLASMS
Phase: EARLY_PHASE1 • Sponsor: Affiliated Hospital to Academy of Military Medical Sciences • Aim: Disease control
Last updated May 26, 2026 12:03 UTC